Table 2

Hospitalized adult patients with 2009 Influenza A (H1N1) in Beijing: complications, definitive treatment, and supportive treatment

Survivor

(n = 128)

Nonsurvivor

(n = 27)

Total

(n = 155)

P value


Complications

Acute respiratory failure

39 (30.5%)

23 (85.2%)

62 (40.0%)

0.003

Septic shock

1 (0.8%)

17 (63.0%)

18 (11.6%)

< 0.001

Acute renal failure

4 (3.1%)

11 (40.7%)

15 (9.7%)

< 0.001

Altered mental status

6 (4.7%)

14 (51.9%)

20 (12.9%)

< 0.001

Bacterial pneumonia

15 (11.7%)

13 (48.1%)

28 (18.1%)

< 0.001

Bloodstream infection

0

3 (11.1%)

3 (1.9%)

0.006

Other infections

0

5 (18.5%)

5 (3.2%)

< 0.001

Antiviral agents

107 (83.6%)

25 (92.6%)

132 (85.2%)

0.371

Oseltamivir treatment

101 (78.9%)

24 (88.9%)

125 (80.6%)

0.259

within 48 hrs of symptom onset

12 (9.4%)

4 (14.8%)

16 (10.3%)

0.507

Broad-spectrum antibiotics

113 (88.3%)

26 (96.3%)

139 (89.7%)

0.309

Corticosteroids

35 (27.4%)

17 (63.0%)

52 (33.5%)

< 0.001

Vasopressors

5 (3.9%)

23 (85.2%)

28 (18.1%)

< 0.001

Inotropes

2 (1.6%)

7 (25.9%)

9 (5.8%)

< 0.001

Neuromuscular blockade

1 (0.8%)

7 (25.9%)

8 (5.2%)

< 0.001

Noninvasive ventilation

19 (14.9%)

13 (48.1%)

32 (20.6%)

< 0.001

Invasive ventilation

19 (14.9%)

24 (88.9%)

43 (27.7%)

< 0.001

Continuous renal replacement therapy

4 (3.1%)

13 (48.1%)

17 (11.0%)

< 0.001


Xi et al. BMC Infectious Diseases 2010 10:256   doi:10.1186/1471-2334-10-256

Open Data